Nabriva Therapeutics plc Contract with Customer, Asset, after Allowance for Credit Loss, Current
Nabriva Therapeutics plc had Contract with Customer, Asset, after Allowance for Credit Loss, Current of $1.00 million as of 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:ContractWithCustomerAssetNetCurrent · last filed 2020-03-12
- 2019-03-31: Contract with Customer, Asset, after Allowance for Credit Loss, Current $1.00M.
- 2018-12-31: Contract with Customer, Asset, after Allowance for Credit Loss, Current $1.50M.
- 2018-09-30: Contract with Customer, Asset, after Allowance for Credit Loss, Current $1.50M.
- 2018-06-30: Contract with Customer, Asset, after Allowance for Credit Loss, Current $1.50M.
| Period end | Contract with Customer, Asset, after Allowance for Credit Loss, Current |
|---|---|
| 2019-03-31 | $1.00M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $1.50M 10-K · filed 2020-03-12 |
| 2018-09-30 | $1.50M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $1.50M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.50M 10-Q · filed 2018-05-08 |